Literature DB >> 21855351

Synthesis and characterization of tritylthioethanamine derivatives with potent KSP inhibitory activity.

Delany Rodriguez1, Chinnasamy Ramesh, Lauren H Henson, Lori Wilmeth, Bj K Bryant, Samuel Kadavakollu, Rebecca Hirsch, Johnelle Montoya, Porsha R Howell, Jon M George, David Alexander, Dennis L Johnson, Jeffrey B Arterburn, Charles B Shuster.   

Abstract

Assembly of a bipolar mitotic spindle requires the action of class 5 kinesins, and inhibition or depletion of this motor results in mitotic arrest and apoptosis. S-Trityl-l-cysteine is an allosteric inhibitor of vertebrate Kinesin Spindle Protein (KSP) that has generated considerable interest due to its anti-cancer properties, however, poor pharmacological properties have limited the use of this compound. We have modified the triphenylmethyl and cysteine groups, guided by biochemical and cell-based assays, to yield new cysteinol and cysteamine derivatives with increased inhibitory activity, greater efficacy in model systems, and significantly enhanced potency against the NCI60 tumor panel. These results reveal a promising new class of conformationally-flexible small molecules as allosteric KSP inhibitors for use as research tools, with activities that provide impetus for further development as anti-tumor agents.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21855351      PMCID: PMC3171608          DOI: 10.1016/j.bmc.2011.07.054

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  61 in total

1.  Inhibitors of human mitotic kinesin Eg5: characterization of the 4-phenyl-tetrahydroisoquinoline lead series.

Authors:  Christine M Tarby; Robert F Kaltenbach; Tram Huynh; Andrew Pudzianowski; Henry Shen; Marie Ortega-Nanos; Steven Sheriff; John A Newitt; Patricia A McDonnell; Neil Burford; Craig R Fairchild; Wayne Vaccaro; Zhong Chen; Robert M Borzilleri; Joseph Naglich; Louis J Lombardo; Marco Gottardis; George L Trainor; Deborah L Roussell
Journal:  Bioorg Med Chem Lett       Date:  2006-02-03       Impact factor: 2.823

2.  Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520.

Authors:  Brian J Tunquist; Richard D Woessner; Duncan H Walker
Journal:  Mol Cancer Ther       Date:  2010-06-22       Impact factor: 6.261

3.  Monastrol inhibition of the mitotic kinesin Eg5.

Authors:  Jared C Cochran; Joseph E Gatial; Tarun M Kapoor; Susan P Gilbert
Journal:  J Biol Chem       Date:  2005-01-23       Impact factor: 5.157

4.  Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of clotrimazole.

Authors:  M Humayun Khalid; Yoshiharu Tokunaga; Anthony J Caputy; Eric Walters
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Kinesin spindle protein (KSP) inhibitors. 9. Discovery of (2S)-4-(2,5-difluorophenyl)-n-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the treatment of taxane-refractory cancer.

Authors:  Christopher D Cox; Paul J Coleman; Michael J Breslin; David B Whitman; Robert M Garbaccio; Mark E Fraley; Carolyn A Buser; Eileen S Walsh; Kelly Hamilton; Michael D Schaber; Robert B Lobell; Weikang Tao; Joseph P Davide; Ronald E Diehl; Marc T Abrams; Vicki J South; Hans E Huber; Maricel Torrent; Thomayant Prueksaritanont; Chunze Li; Donald E Slaughter; Elizabeth Mahan; Carmen Fernandez-Metzler; Youwei Yan; Lawrence C Kuo; Nancy E Kohl; George D Hartman
Journal:  J Med Chem       Date:  2008-06-25       Impact factor: 7.446

6.  A Bayesian population PK-PD model for ispinesib/docetaxel combination-induced myelosuppression.

Authors:  Steven J Kathman; Daphne H Williams; Jeffrey P Hodge; Mohammed Dar
Journal:  Cancer Chemother Pharmacol       Date:  2008-04-29       Impact factor: 3.333

7.  A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168).

Authors:  Jennifer J Knox; Sharlene Gill; Timothy W Synold; James J Biagi; Pierre Major; Ron Feld; Christine Cripps; Nancy Wainman; Elizabeth Eisenhauer; Lesley Seymour
Journal:  Invest New Drugs       Date:  2008-01-15       Impact factor: 3.850

8.  Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.

Authors:  Rahul Palchaudhuri; Paul J Hergenrother
Journal:  Bioorg Med Chem Lett       Date:  2008-08-03       Impact factor: 2.823

9.  Loop L5 acts as a conformational latch in the mitotic kinesin Eg5.

Authors:  William M Behnke-Parks; Jeremie Vendome; Barry Honig; Zoltan Maliga; Carolyn Moores; Steven S Rosenfeld
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

10.  Kinesin-5 motors are required for organization of spindle microtubules in Silvetia compressa zygotes.

Authors:  Nick T Peters; Darryl L Kropf
Journal:  BMC Plant Biol       Date:  2006-08-31       Impact factor: 4.215

View more
  5 in total

1.  A Splice Variant of Centrosomin Converts Mitochondria to Microtubule-Organizing Centers.

Authors:  Jieyan V Chen; Rebecca A Buchwalter; Ling-Rong Kao; Timothy L Megraw
Journal:  Curr Biol       Date:  2017-06-29       Impact factor: 10.834

2.  Clotrimazole as a Cancer Drug: A Short Review.

Authors:  S Kadavakollu; C Stailey; C S Kunapareddy; S White
Journal:  Med Chem (Los Angeles)       Date:  2014

3.  Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement.

Authors:  Mohamed O Radwan; Halil I Ciftci; Taha F S Ali; Doha E Ellakwa; Ryoko Koga; Hiroshi Tateishi; Akiko Nakata; Akihiro Ito; Minoru Yoshida; Yoshinari Okamoto; Mikako Fujita; Masami Otsuka
Journal:  Molecules       Date:  2019-09-10       Impact factor: 4.411

4.  NiXantphos: a deprotonatable ligand for room-temperature palladium-catalyzed cross-couplings of aryl chlorides.

Authors:  Jiadi Zhang; Ana Bellomo; Nisalak Trongsiriwat; Tiezheng Jia; Patrick J Carroll; Spencer D Dreher; Matthew T Tudge; Haolin Yin; Jerome R Robinson; Eric J Schelter; Patrick J Walsh
Journal:  J Am Chem Soc       Date:  2014-04-21       Impact factor: 15.419

5.  Nitrogen-Containing Secondary Metabolites from a Deep-Sea Fungus Aspergillus unguis and Their Anti-Inflammatory Activity.

Authors:  Cao Van Anh; Yeo Dae Yoon; Jong Soon Kang; Hwa-Sun Lee; Chang-Su Heo; Hee Jae Shin
Journal:  Mar Drugs       Date:  2022-03-20       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.